Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

In Hep B, Functional Cure Likely Means Two-Part Combination Process

Nov 23 2017

• By Joseph Haas

Hep B_1200

Related Content

US, EU Nods For Gilead's Vemlidy To Enter Saturated Hep B Market

Nov 11 2016

Deal Watch: Gilead And Spring Bank Set Second Trial Collaboration In HBV

Jul 14 2017

ContraVir Strikes Deal With Rival Early Stage Hep B Drug Developer

Jun 01 2016

ContraVir Hopes To Establish Backbone For Hepatitis B Combo Therapy

Jul 25 2016

Related Companies

Hepion Pharmaceuticals, Inc.

Gilead Sciences, Inc.

Spring Bank Pharmaceuticals Inc.

Arbutus Biopharma Corporation

Arrowhead Pharmaceuticals, Inc.

Replicor Inc.

Johnson & Johnson

Hepion Pharmaceuticals, Inc.

Additional Topics

Clinical Trials Business Strategies Research & Development Infectious Diseases BioPharmaceutical

More from Anti-infective

More from Therapeutic Category

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window